€93.62
0.36% yesterday
Borsa Italiana, May 20, 05:35 pm CET
ISIN
IT0003492391
Symbol
DIA
Sector

DiaSorin S.p.A. Stock price

€93.62
-4.30 4.39% 1M
-11.28 10.75% 6M
-5.94 5.97% YTD
-6.32 6.32% 1Y
-25.53 21.43% 3Y
-95.58 50.52% 5Y
+52.54 127.88% 10Y
Borsa Italiana, Closing price Tue, May 20 2025
-0.34 0.36%
ISIN
IT0003492391
Symbol
DIA
Sector

Key metrics

Market capitalization €5.05b
Enterprise Value €5.66b
P/E (TTM) P/E ratio 27.28
EV/FCF (TTM) EV/FCF 18.47
EV/Sales (TTM) EV/Sales 4.78
P/S ratio (TTM) P/S ratio 4.26
P/B ratio (TTM) P/B ratio 2.80
Dividend yield 1.28%
Last dividend (FY24) €1.20
Revenue growth (TTM) Revenue growth 3.24%
Revenue (TTM) Revenue €1.19b
EBIT (operating result TTM) EBIT €277.65m
Free Cash Flow (TTM) Free Cash Flow €306.66m
EPS (TTM) EPS €3.35
P/E forward 24.70
P/S forward 4.04
EV/Sales forward 4.53
Show more

Is DiaSorin S.p.A. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

DiaSorin S.p.A. Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a DiaSorin S.p.A. forecast:

6x Buy
38%
9x Hold
56%
1x Sell
6%

Analyst Opinions

16 Analysts have issued a DiaSorin S.p.A. forecast:

Buy
38%
Hold
56%
Sell
6%

Financial data from DiaSorin S.p.A.

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
1,185 1,185
3% 3%
100%
- Direct Costs 459 459
0% 0%
39%
726 726
6% 6%
61%
- Selling and Administrative Expenses 228 228
2% 2%
19%
- Research and Development Expense 92 92
1% 1%
8%
407 407
9% 9%
34%
- Depreciation and Amortization 129 129
6% 6%
11%
EBIT (Operating Income) EBIT 278 278
18% 18%
23%
Net Profit 188 188
18% 18%
16%

In millions EUR.

Don't miss a Thing! We will send you all news about DiaSorin S.p.A. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics. It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis & retrovirus, oncology and endocrinology. The company was founded in 1968 and is headquartered in Vercelli, Italy.

Head office Italy
CEO Carlo Rosa
Employees 3,271
Founded 1968
Website www.diasorin.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today